INTER-LOCAL: International Funding Call for Clinical Research into Local Treatment Strategies for Rare and Hard-to-Treat Cancers

Eligibility & scope

Supports late-phase (phase 2/3) international clinical trials focused on radiotherapy or surgery as core experimental interventions for rare cancers (incidence <6/100,000/year) and/or hard-to-treat cancers (5-year survival <25%). Requires partners from at least 3 of 5 funding countries; clinical-trial focus with mandatory patient involvement and quality-of-life assessment plans.